Quantum Computing (QUBT) Q2 2025 Earnings Call August 14, 2025 04:30 PM ET Company ParticipantsRosalyn Christian - Account ManagerYuping Huang - CEO & ChairmanChris Roberts - CFOTroy Jensen - Managing DirectorOperatorLadies and gentlemen, greetings, and welcome to the Quantum Computing Inc. Second Quarter twenty twenty five Shareholder Update Call. At this time, all participants are in a listen only mode. Please note this call is being recorded. Following management's remarks, the call line will be open for ...

Financial Data and Key Metrics Changes - Revenue for the fourth quarter was $1.9 billion, up 12% quarter over quarter and 8% year over year, exceeding guidance [5][17] - Non-GAAP earnings per share for the quarter were $0.29, above the guidance range of a loss of $0.10 to a profit of $0.15 [19] - Non-GAAP gross margin for the fourth quarter was 26.4%, up 370 basis points from the prior quarter [18] Business Line Data and Key Metrics Changes - Cloud revenue for the fourth quarter was $213 million, up 8% sequentially and 25% year over year [18] - Client revenue was $1.1 billion, up 19% sequentially and 3% year over year [18] - Consumer revenue was $585 million, up 2% quarter over quarter and 12% year over year [18] Market Data and Key Metrics Changes - Data center represented over 12% of total bits shipped in the fourth quarter, indicating significant growth in this market [9] - Hyperscale capital expenditure in the U.S. is estimated to grow 47% year over year to $368 billion, with rising investments in Asia and Europe [11] Company Strategy and Development Direction - The company is transitioning to BIX-eight as its prominent node, which is expected to drive significant financial improvement and expanding margins [7][8] - The strategy focuses on the adoption of QLC-based SSDs and PCIe Gen five and six solutions to meet the demands of AI and data-intensive workloads [11][12] - Continued innovation in flash-based storage is emphasized, with a commitment to product development and strategic partnerships in the gaming sector [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about fiscal year 2026, anticipating a favorable supply-demand dynamic and continued demand exceeding supply [6][27] - The company plans to manage supply in line with demand, adjusting wafer starts and underutilizing fabs when necessary [22] - Management highlighted the importance of navigating tariffs and maintaining a competitive edge in the global market [60] Other Important Information - The company reduced inventory days from 150 to 135, reflecting improved demand-supply alignment [20] - A significant focus on high bandwidth flash memory technology was noted, with expectations for product samples by 2027 [15][16] Q&A Session Summary Question: Can you provide more depth on gross margins? - Management indicated that underutilization costs are decreasing, with startup costs impacting gross margins significantly [30] Question: What is the strategy behind the high bandwidth flash partnership? - The partnership aims to standardize technology for broader applicability across various markets, including AI workloads [34][36] Question: How do you view the growth in client demand in the second half of the year? - Management sees consistent demand from customers, with normalized inventory levels and an undersupplied market [58] Question: What is the outlook for the data center side? - The company aims to increase its market share in the data center segment, with ongoing qualifications and product launches [66] Question: How is the company navigating competitive dynamics in China? - The company views China as an attractive market and is confident in its ability to compete effectively [82] Question: What are the expectations for startup costs moving forward? - Management expects startup costs to decrease significantly in the upcoming quarters, with minimal impacts anticipated [46][71]

Financial Data and Key Metrics Changes - Applied Materials reported total net revenue of approximately $7.3 billion, an 8% increase year over year, exceeding guidance by about $100 million [19] - Non-GAAP gross margin was 48.9%, up 150 basis points year over year, driven by product mix and pricing strategies [19] - Non-GAAP earnings per share reached a record $2.48, reflecting a 17% year-over-year increase due to revenue growth and share repurchases [20] Business Line Data and Key Metrics Changes - Semiconductor Systems revenue was $5.43 billion, up 10% year over year, with growth in foundry logic and DRAM, partially offset by declines in ICAPS nodes [20] - Applied Global Services (AGS) revenue was $1.6 billion, a 1% increase year over year, with core services growing approximately 10% [21] - Display business revenue was $263 million, with a non-GAAP operating margin of 23.6% [22] Market Data and Key Metrics Changes - China accounted for approximately 35% of revenue in Q3, expected to decrease to about 29% in Q4 due to moderating customer spending [24] - The company is tracking over 100 new fabs or major fab expansion projects globally, a 10% increase from the previous year [9] Company Strategy and Development Direction - The company plans to invest over $200 million in Arizona to establish a state-of-the-art facility for manufacturing specialized components [9] - Applied Materials is focusing on AI leadership, with significant investments in infrastructure and R&D to support advanced manufacturing capacity [8] - The company expects to grow its advanced packaging business to over $3 billion in the coming years, driven by innovations in energy-efficient computing [13][71] Management's Comments on Operating Environment and Future Outlook - Management anticipates sequentially lower revenue and earnings in Q4 due to uncertainties in the China business and nonlinear demand from leading-edge customers [5][24] - Despite short-term challenges, the long-term growth thesis for the semiconductor industry remains intact, with expectations for market share gains as new technologies ramp up [17][26] Other Important Information - The company generated approximately $2.6 billion in cash from operations, representing 36% of revenue, and distributed about $1.4 billion to shareholders through dividends and share repurchases [23] - Non-GAAP operating expenses were $1.3 billion, slightly down as a percentage of revenue due to optimized spending [19] Q&A Session Summary Question: Can you discuss the incremental source of weakness in the outlook, particularly regarding China and leading-edge logic? - Management indicated that lower visibility in China is expected to persist for several quarters, with a significant backlog of pending export license applications affecting outlook [30][31] Question: Was China significantly stronger than expected in Q3? - Management confirmed that the quarter played out as expected, with no major surprises in the mix, although leading-edge spending was slightly less than anticipated [38][39] Question: What are the expectations for DRAM growth and its sustainability? - Management expressed confidence in strong DRAM growth, expecting it to be either a record or nearly record year, driven by leading-edge customers [85] Question: How is the advanced packaging segment expected to perform? - Management expects steady growth in advanced packaging, with plans to double the business to over $3 billion in the coming years [71] Question: What is the outlook for leading-edge logic and the associated share position? - Management remains confident in their strong position with leading-edge logic customers, expecting significant revenue growth as new technologies ramp [111][114]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was €614.2 million, representing a 4.5% year-over-year growth, with a 1% growth in organic constant currency and 0.5% sequential growth [7][32] - Non-IFRS adjusted operating margin was 15% for the quarter, maintaining stability despite foreign exchange headwinds [32] - Non-IFRS adjusted diluted EPS for the quarter was $1.53, an increase from $1.51 in the previous year [32] - Free cash flow for the quarter was negative $2.9 million, an improvement from negative $28 million in the same period last year [33] Business Line Data and Key Metrics Changes - The AI Pods model has gained traction, with 18 clients adopting the subscription model, contributing significantly to pipeline growth [10][41] - The company reported 49 clients generating over €10 million in annual revenue, up from 39 a year ago [20] - The revenue mix is diverse, with North America accounting for 54.1%, Latin America 19.7%, Europe 19.6%, and new markets 6.6% [18][19] Market Data and Key Metrics Changes - North America remains the largest market, but Latin America showed strong recovery with new records in bookings [18][19] - Europe is the fastest-growing region, up 8.1% sequentially, with major wins in aviation and financial services [19] - New markets grew 84% year-over-year, with the Middle East leading this surge [19] Company Strategy and Development Direction - The company is focusing on AI-driven solutions and has launched a new go-to-market strategy centered around AI industry studios and the 100 square accounts [34] - A business optimization plan was executed, resulting in a reduction of approximately 1,000 employees (3% of the workforce) to align with strategic priorities [35] - The company aims to ensure structural agility to compete effectively in an evolving landscape while delivering strong results for shareholders [8][21] Management's Comments on Operating Environment and Future Outlook - Management noted that the macro environment has extended sales cycles, but they remain optimistic about converting the pipeline into signed work [7][50] - The company expects revenue for 2025 to be at least $2.445 billion, representing 1.2% year-over-year growth [38] - Management expressed cautious optimism regarding the recovery in North America and Latin America, with signs of stabilization and growth [72][74] Other Important Information - The company has strengthened its position in the robotics and AI ecosystem by investing in InOrbit, enhancing capabilities in advanced orchestration of robotic systems [17] - A multiyear collaboration with OpenAI and a strategic partnership with Amazon Web Services were announced to enhance AI adoption [15][30] Q&A Session Summary Question: Inquiry about the AI-based delivery model and subscription clients - Management confirmed that 18 clients have adopted the subscription model, which has been well received and is generating significant pipeline growth [41][44] Question: Discussion on optimization progress and headcount reduction - Management indicated that additional reductions are expected in Q3, with most of the optimization plan already implemented [52][53] Question: Performance of the creative pillar relative to other studios - Management noted that the creative pillar has been growing nicely and is not expected to be significantly impacted by AI [56][60] Question: Stickiness of the enterprise AI platform compared to traditional engagements - Management stated that the enterprise AI platform is becoming essential for clients, enhancing engagement and reducing churn [66][68] Question: Details on larger deals in the pipeline - Management highlighted significant deals in the financial services and healthcare sectors in the US, indicating a positive trend in the pipeline [71][72] Question: Assumptions around revised growth outlook and conservatism - Management explained that the revised guidance reflects stabilization in Latin America and a positive outlook for the US market [77][78] Question: North American deceleration and pipeline conversion trends - Management acknowledged a sequential decline in North America but expressed optimism about pipeline growth and deal closures [94][95]

Financial Data and Key Metrics Changes - Applied Materials reported total net revenue of approximately $7.3 billion, an 8% increase year over year, exceeding guidance by about $100 million [17] - Non-GAAP gross margin was 48.9%, up 150 basis points year over year, driven by product and segment mix and pricing [17] - Non-GAAP earnings per share reached a record $2.48, a 17% increase year over year [18] Business Segment Data and Key Metrics Changes - Semiconductor Systems revenue was $5.43 billion, up 10% year over year, with growth in foundry logic and DRAM, partially offset by decreases in ICAPS nodes [18] - Applied Global Services (AGS) revenue was $1.6 billion, up 1% year over year, with core services growing approximately 10% [19] - Display business revenue was $263 million, with a non-GAAP operating margin of 23.6% [20] Market Data and Key Metrics Changes - China accounted for approximately 35% of revenue in Q3, expected to decrease to about 29% in Q4 due to moderating customer spending [21] - The company is tracking over 100 new fabs or major fab expansion projects globally, a 10% increase from the previous year [7] Company Strategy and Development Direction - The company plans to invest over $200 million in Arizona to establish a state-of-the-art facility for manufacturing specialized components [7] - Applied Materials is focused on leadership in AI, with significant investments in infrastructure and R&D to support advanced manufacturing capacity [6] - The company expects to grow its advanced packaging business to over $3 billion in the coming years, driven by innovations in power electronics and energy-efficient computing [12][69] Management's Comments on Operating Environment and Future Outlook - Management anticipates sequentially lower revenue and earnings in Q4 due to uncertainties in the China business and nonlinear demand from leading-edge customers [4][21] - Despite short-term challenges, the long-term growth thesis for the semiconductor industry remains intact, with expectations for continued market share gains [15][24] - Management highlighted that the demand for DRAM is expected to grow by around 50% in fiscal 2025, driven by AI-related technologies [11][50] Other Important Information - The company generated approximately $2.6 billion in cash from operations, representing 36% of revenue, and distributed about $1.4 billion to shareholders through dividends and share repurchases [20] - Non-GAAP operating expenses were $1.3 billion, slightly down as a percentage of revenue due to optimized G&A spending [17] Q&A Session Summary Question: Concerns about the outlook for China and leading-edge logic - Management indicated that lower visibility in China is expected to persist for several quarters, with a digestion phase following large shipments in previous years [28][29] - The leading-edge logic demand is strong, but order patterns are uneven due to market concentration and timing issues [30][31] Question: Clarification on China revenue strength - Management confirmed that the quarter played out as expected, with no significant changes in the flow from leading-edge spending [36][37] Question: Future growth expectations for DRAM - Management expects DRAM growth to be sustainable, with strong demand driven by leading-edge customers [82] Question: Advanced packaging growth expectations - Management anticipates steady growth in advanced packaging, with plans to double the business to over $3 billion in the coming years [69][70] Question: Licensing backlog impact - Management highlighted a significant backlog of pending export licenses but did not include any revenue from this backlog in their outlook [59][60]

Financial Data and Key Metrics Changes - In Q2 2025, the company achieved record revenue of approximately $4 million, up 63% from the same quarter in 2024 [5][26] - The first quarterly profit was reported at $0.22 per share, attributed to the Bitcoin treasury strategy [5] - The balance sheet includes approximately $140 million in cash and Bitcoin, indicating strong capitalization for growth [6][29] - Product revenue increased by 74% year over year, while service revenue decreased by 57% [27] Business Line Data and Key Metrics Changes - Product revenue per customer grew by 4.6%, while service revenue per customer declined by 50% [27] - Gross margin for Q2 was 18%, down due to unanticipated labor hours and Bitcoin price effects [28] - The company is transitioning from a design and testing service model to a product-focused model, with expectations to double revenue in 2025 compared to 2024 [6][7] Market Data and Key Metrics Changes - The subsea battery system market is projected to grow from approximately $1.2 billion in 2024 to $3.5 billion by 2035 [20] - The company is exploring new markets, including exoskeleton technology, which is expected to grow quickly and contribute to revenue in 2025 [23] Company Strategy and Development Direction - The company aims to leverage its Bitcoin treasury strategy to build a portfolio of frontier technologies, including high-performance energy systems and AI robotics [13][24] - The Cooler One platform is positioned as a key growth engine, with plans to introduce new products for unmanned vehicles and industrial applications [6][7] - The company is focused on enhancing shareholder communications and addressing negative sentiments in the market [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, emphasizing the importance of the Cooler One platform and its advanced battery products [16][21] - The management acknowledged the challenges posed by negative market sentiments and short-selling reports but remains focused on long-term growth [11][72] Other Important Information - The company has no material debts and maintains a strong cash position, with a current accounts receivable of about $4.2 million [29] - The reverse stock split was executed to attract institutional investors, not for compliance reasons [9][12] Q&A Session Summary Question: What is the traction with DOD regarding Vibe and helicopters? - The product can balance various helicopters, and significant work has been done with DOD customers [30][31] Question: Why are SG&A costs increasing while sales growth is not keeping pace? - SG&A costs reflect planned investments for future growth, despite record revenue [33][34] Question: Why should shareholders continue to hold shares given dilution concerns? - The ATM strategy has strengthened the balance sheet, allowing for continued investment in growth areas [36][37] Question: Is there any class action lawsuit against the company? - The company is not aware of any class action litigation against it or its officers [44] Question: What is the current status of the K1DS testing services division? - The investment in K1DS has been completed, and the focus is now on strategic key customers [63] Question: What is the rationale behind the reverse stock split? - The reverse split was voluntary to attract institutional investors and strengthen the shareholder base [39][66] Question: What is the company's strategy regarding Bitcoin and product development? - Bitcoin is a key part of the treasury strategy, but the company continues to focus on technology and product development [76] Question: What is the current hash rate and target for Bitcoin mining? - The current hash rate is approximately 900 petahash, with a target to reach one exahash by fall [77][78] Question: What is the status of the Texas Space Commission order? - The grant program is progressing well, and a satellite manufacturing partner is being selected [79]

Financial Data and Key Metrics Changes - The company reported revenue of $11.1 million, a $2.1 million or 22% increase year-over-year, with a gross margin of 57% compared to 51% last year, significantly above guidance of 45% to 50% [14] - The net loss for the quarter was $3.5 million, with adjusted EBITDA of negative $2.1 million, compared to a net loss of $3.1 million and adjusted EBITDA of $1.4 million in the prior year quarter [14][15] - Cash and cash equivalents stood at $2 million as of June 30, 2025, with $8.9 million available on a $12.5 million working capital facility [15][16] Business Line Data and Key Metrics Changes - Streaming business delivered 4 billion total minutes viewed, up 38% year-over-year, and 20% sequentially, with total streaming viewers climbing to 214 million, up 24% [17][18] - Subscriber count grew to 1.4 million, an increase of 5% year-over-year and 1% over the prior quarter [18] - The advertising business saw a 57% year-over-year growth driven by new and returning advertisers, despite mixed performance in open market programmatic [19] Market Data and Key Metrics Changes - The company is entering the microseries market, projected to reach $10 billion by February 2027, with a joint venture for MicroCo aimed at becoming a first mover in this rapidly growing market [12][26] - The Cineverse channel has grown more than 4300% since January, indicating strong traction in the market [18] Company Strategy and Development Direction - The company is focusing on expanding its theatrical releasing business and building out its technology product, with significant investments in sales, legal, marketing, and technology [7][14] - The strategy includes leveraging unique assets in streaming, content, technology, and AI to create a competitive advantage in the microseries space [13][26] - The Motion Picture Group is building a strong slate of wide releases, targeting identifiable audiences and creating event viewing experiences [27][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in seeing strong returns from investments made in the current quarter, expecting improved top and bottom line results for the remainder of the fiscal year [7][14] - The company is optimistic about the upcoming releases, including "The Toxic Avenger" and "Air Bud Returns," which are expected to resonate well with audiences [10][11][28] - Management highlighted the importance of engaging with fans and delivering films they want to see, emphasizing a commitment to innovative approaches in distribution and marketing [31][32] Other Important Information - The company has no long-term debt and has reduced outstanding warrants to 700,000, positioning itself favorably for future growth [15][16] - The marketing campaign for "The Toxic Avenger" was noted as a significant success, receiving extensive media coverage and positive fan engagement [30] Q&A Session Summary Question: Why partner with Cineverse for MicroCo? - Management highlighted the unique collection of assets Cineverse has built, making it an attractive partner for entering the microseries market, which is expected to be a $10 billion business [36][41] Question: What is the investment strategy for MicroCo? - The company plans to bootstrap and fund the launch internally with potential for additional equity partners if needed, emphasizing the scalability of the business [45] Question: What progress has been made with MatchPoint technology? - Management reported significant inroads in bringing MatchPoint to market, with a tripled pipeline of potential deals and a focus on targeting larger studios for meaningful revenue [51][52] Question: How is the podcast revenue strategy evolving? - The company is shifting from programmatic sales to direct sales with a dedicated team, already seeing significant deals coming in, indicating a strong belief in future revenue growth from this segment [55][56]

Financial Data and Key Metrics Changes - Revenue net of returns totaled $86,000 for Q2 2025 compared to $140,000 in Q2 2024, and $156,000 for the first half of 2025 compared to $474,000 for the first half of 2024, reflecting a significant decline due to decreased unit sales of ClearUp [16][17] - Cost of sales decreased to $32,000 from $110,000 in the year-ago quarter, and gross margins increased to 63% for Q2 2025 compared to 21% a year ago, driven by reductions in product support and fulfillment costs [17][18] - Net loss was $1,900,000 for Q2 2025 compared with $1,300,000 for Q2 2024, and $3,400,000 for the first half of 2025 compared with $2,700,000 for the first half of 2024 [18][19] Business Line Data and Key Metrics Changes - The decline in revenue was primarily due to reduced unit sales of ClearUp, as the company intentionally decreased marketing expenditures to focus on advancing its TLR5 program [17] - Operating expenses increased to $2,000,000 for Q2 2025 compared with $1,300,000 for Q2 2024, mainly due to increased research and development investments in the biologics program [18] Market Data and Key Metrics Changes - The market for neutropenia drugs is projected to be between $19 billion to $24 billion over the next few years, with entolimod potentially addressing a significant portion of this market [10] Company Strategy and Development Direction - The company is transitioning towards the biopharmaceutical market and away from the consumer device market, planning to exit the consumer health tech business by year-end [14] - The exclusive licensing of Sotero Biopharma's TLR5 portfolio is expected to provide a late-stage, highly derisked drug candidate, with significant sales potential from government contracts for acute radiation syndrome (ARS) treatments [4][5] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the potential of entolimod and its derivatives to treat radiation and chemotherapy side effects, emphasizing the importance of their strategic pipeline [11][12] - The company is focused on advancing its clinical and commercial opportunities, with key milestones including the transfer of existing INDs and validation of GMP materials [22][23] Other Important Information - The company raised gross proceeds of $900,000 through equity financing, which will support progress towards GMP manufacturing validation for entolimod [19] - Management highlighted the importance of talent acquisition to support clinical work and government relations, indicating a strategic alignment with their new focus [21] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - Consolidated net sales for Q2 2025 were $12.7 million, a decrease of approximately $800,000 or 6.7% compared to Q2 2024 [9] - Gross profit was $2 million, representing 16% of sales for Q2 2025 [9] - Adjusted EBITDA for the first half of 2025 was $1.469 million, a decrease of $306,000 or 17% from the prior year [10] - The company reported a net loss of $422,000 or $0.11 per share in 2025, compared to net income of $298,000 or $0.09 per share in 2024 [10] Business Line Data and Key Metrics Changes - The company faced delays in customer approvals and extended lead times from subcontractors, impacting overall results [4] - Cost-cutting initiatives, including a workforce reduction, are expected to save approximately $1 million annually [5] - The backlog grew to record levels, indicating sustained demand for products, with significant contracts such as a $5 million order for landing gear components for the B-52 aircraft [6] Market Data and Key Metrics Changes - The company noted that long lead times for raw materials and complex product manufacturing mean that sales from the backlog will primarily be realized in fiscal 2026 and beyond [6][7] - The business development team has been actively pursuing new opportunities, particularly following the Paris Air Show [7] Company Strategy and Development Direction - The company is focused on recovering from decreased revenue streams with legacy customers while reinforcing relationships with existing clients and expanding into new markets [12] - Recent accomplishments include receiving a significant long-term agreement from Northrop Grumman and increasing content on the CH-53K helicopter [13] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the disappointing results for Q2 2025 but expressed confidence in the long-term business outlook despite recent headwinds [5] - The company anticipates that the fourth quarter of 2025 will be the strongest quarter of the year [5] - Management emphasized that the backlog is healthy and that delays in customer approvals are temporary [32] Other Important Information - The company successfully completed an at-the-market offering, raising nearly $4 million, which enhances liquidity and reduces net debt [11] - Total debt has declined by over $1 million, while inventory has increased by about $1.3 million [11] Q&A Session Summary Question: Concerns about credit facility and liquidity - Management is in discussions with the current lender and is confident about extending the credit facility [19][20] Question: Nature of recent capital raise - The capital raise was part of a planned process initiated in December 2024, not solely opportunistic [21] Question: European sales potential - The company does not have significant European customers but is optimistic about potential sales due to increased European defense spending [23][26] Question: Clarification on declining sales - Sales decline is attributed to timing issues with customer approvals and delays in first articles [32][33] Question: Consideration of selling the company - Management stated that while sales have been stagnant, there has been growth in certain operations, and they are open to opportunities that benefit shareholders [36][39] Question: Backlog conversion rates - The backlog consists of firm and full backlog, with a significant portion being firm orders that cannot be easily canceled [41][43] Question: Future of manned aircraft vs. drones - Management believes that manned aircraft will continue to play a crucial role alongside drones, as they are not expected to be replaced in the near future [46][48]

Financial Data and Key Metrics Changes - For Q2 2025, the company generated total revenue of $1.7 million, consisting of $1.6 million in net product sales from Zunveil and $81,000 in licensing revenue from CMS [13] - Total costs and expenses for the quarter were $7.4 million, leading to an operating loss of $5.7 million compared to a loss of $2.4 million in Q2 2024 [14] - The net loss for Q2 2025 was $10.5 million or $0.65 per share, compared to a net loss of $2.1 million or $0.35 per share in the same quarter last year [15] Business Line Data and Key Metrics Changes - The commercial launch of Zunveil has seen prescriptions written in over 300 nursing homes, with 65% of these facilities placing repeat orders, indicating strong product trial [6][18] - The company reported approximately $2 million in net product revenues for Zunveil since its launch [13] Market Data and Key Metrics Changes - The company engaged with over 3,700 healthcare providers (HCPs) in the long-term care market during the quarter [6] - By the end of Q2, Zunveil had been ordered in over 300 long-term care homes, with 90% of orders filled despite increased prior authorization hurdles [20] Company Strategy and Development Direction - The company is focused on expanding Zunveil's presence in the long-term care market and optimizing its commercial strategy to enhance engagement with prescribers [27] - The company plans to advance its sublingual formulation and conduct a comparative pharmacokinetic study, with an IND submission anticipated in 2026 [7][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the initial traction of Zunveil and the potential for scalable growth in the coming quarters [13][17] - The company remains committed to disciplined expense management and anticipates full-year operating expenses in the range of $34 million to $38 million [16] Other Important Information - The company has made significant progress with its first ex-US partner, CMS Pharmaceuticals, which is on track to file in four additional countries by 2025 [11] - The company is well-capitalized with approximately $39.4 million in unrestricted cash as of June 30, 2025 [15] Q&A Session Summary Question: Can you characterize the typical profile of a repeat prescriber of Zunveil? - The company has identified high-volume nursing home facilities with a significant number of Alzheimer's patients as key targets for repeat prescriptions [31] Question: What is the expected state of contracting by the end of the year? - The company expects to have at least one more large national plan contracted by the end of the year, in addition to the existing contract [33] Question: Can you provide insights on prior authorization challenges? - The company has seen an increase in prior authorizations but reports that 90% of orders are being filled, albeit with some delays [39] Question: What is the anticipated monthly net revenue run rate for Q3? - The company anticipates a range of $5.75 to $6.25 million for the monthly net revenue run rate [41] Question: When should the second $3 million tranche from CMS be expected? - The company expects to receive the tranche in the last quarter of this year based on current progress [52] Question: Do you see any changes to the expected hockey stick-shaped revenue curve? - The company maintains its expectations for a hockey stick-shaped revenue curve, with significant growth anticipated in late 2026 and early 2027 [56]